Possibilities of analytical methods and mathematical statistics in pharmacoeconomic studies

Full Text:
Read (RU)

Suggested citation:

Umarov SZ, Dorovskikh IV. [Possibilities of analytical methods and mathematical statistics in pharmacoeconomic studies]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2016;(1):54-58. Russian

Abstract

The possibility of realization for purposes of pharmacoeconomic studies of correlation analysis method for quantify the effect of various factors on effectiveness of investigational medicinal product was considered. In terms
of a number of correctors of cerebral blood flow shows significant effect of them on headache (k>0.7), motion activity (> 0.8, faintness (k=0.767). Analytical characteristics of direct costs in case of treatment with some nootropic drugs is given.

References

1. Gilyarevsky S.R., Orlov V.A. Using the analysis of the effectiveness of treatment for clinical decision making in cardiology. Kardiologiya [Cardiology]. 1997; Vol. 9: 70–80. (in Russian) 2. Kovtunovich M.G. Exacerbation of chronic cerebrovascular insufficiency in somatic patients in a general hospital. Materialy Rossiyskoy nauchno-prakticheskoy konferentsii «Terapevticheskie problemy pozhilogo cheloveka» 27–29 oktyabrya 2010 g. [Proceedings of the Russian Scientific and Practical Conference “Therapeutic problems of an old man” on October 27–29, 2010]. St. Petersburg, 2010: 362. (in Russian) 3. Trofimova E.O. The methodology analyzes of the pharmaceutical market: Autoabstract of diss. St. Petersburg, 2007: 48 р. (in Russian) 4. Economic evaluation of the effectiveness of drug therapy (pharmacoeconomic analysis). Ed. PA Vorobyov. Moscow : N’yuamed, 2000: 80 р. (in Russian) 5. Drummond M.F. Resource allocation decision in health care: a role for quality of life assessments? J Chron Dis. 1987; Vol. 40. N 6: 605–16. 6. О’Brien B. Principles of economic evaluation for health care programs. J Rheumatol. 1995; Vol. 22. N 7: 1399–1402. 7. Jonsson B. Measurement of health outcome and associated costs in cardiovascular disease. Eur Heart J. 1996; Vol. 17, suppl. A: 2–7.



DOI: http://dx.doi.org/10.24411/1560-957X-2016-1%25x

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM